AI assistant
El.En. — Investor Presentation 2022
Mar 21, 2022
4393_cp_2022-03-21_19a1386f-dd10-4b08-a8b8-fc2a2b227e20.pdf
Investor Presentation
Open in viewerOpens in your device viewer
COMPANY PRESENTATION
EURONEXT STAR CONFERENCE
March 22, 2022
DISCLAIMER
Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-lookingstatements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.
AGENDA
- 1.Overview
- 2.Markets and Growth drivers
- 3.Innovation: products & applications
- 4.Financial Highlights
- 5.Current Outlook
- 6.Multiples & Comparables
A primary player providing Medical, Industrial and Conservation Laser Solutions Worldwide
World Class Hi-Tech company
Hi-Tech industrial group providing laser solutions with proprietary technologies and know how developed over 40 years
Listed on Milan's Stock Exchange Star segment since year 2000
Within Worldwide leaders in its space
Active worldwide on several laser application segments and markets…
…progressively widening its worldwide presence achieving continuous growth over the years
WE CREATE LIGHT, ENERGY, WAVES
Medical
Our energy based systems improve people's well-being and life quality.
In the surgical sector, our minimally invasive technology systems minimize pain, side effects and risks of surgical procedures andhospitalization days.
In the aesthetic sector, our systems satisfy the growing desire of individuals to improve their appearance also reducing pathological or painful imperfections
Conservation
Our laser systems preserve artworks of the universal heritage of our communities.
Industrial
Our laser cutting and marking systems reduce the environmental impact of manufacturing processes minimizing waste, fumes generated by the process, use of chemical additives, also allowing to eliminate the need for inks, solvents or glues within the process.
6
Coolwaves® by (Deka Mela S.r.l.) first body-contouring microwaves
Incorporation of EsthelogueS.r.l.
MediostarNext(Asclepion GmbH)
Cutlite Penta S.r.l. costituisce la seconda joint venture cinese Penta Laser Equipment (Wenzhou) Co.Ltd
Juliet® (Asclepion GmbH) for vagina atrophy
organizations under the Reinassance® brand
con Moveo (Deka Mela S.r.l.) hair removal and
Deka M.E.L.A.S.r.l.and Quanta System S.p.A. join the Italian sales
2011
2013
2016
MotusAX
2018
ONDA
system
pigmented lesions
2010
SmartXide2 (Deka Mela S.r.l.) CO2 laser with RF laser source for dermatologicand aesthetic surgery
(Cutlite Penta S.r.l.) Laser Cutting system with
PlusRF
for hair removal 2012
2009
El.En.RF laser sourceo
MonnaLisaTouch® (Deka Mela S.r.l.) for vaginal atrophy treatment
Cyber(Quanta System S.p.A.) surgical device for stones and BPH
2015
Bolt(Penta Chutian e Wenzhou - Cina) high power laser metal cutting system
Discovery Pico (Quanta System S.p.A.) tatoo removal, pigmented lesions and dermatologic treatments
HIROTT (ASA S.r.l.) painful pathologies of the musculoskeletal system
Fiber Plus(Cutlite Penta S.r.l.) first fiber laser metal cutting system
2017
RF 1222"The Big Boy"
2019
Incorporation in Lin Yi of Penta LaserTechnology (Shangdong) Co.Ltd
Glide (dermatology)
2020
Schwarzy (magnetotherapy) Red Touch (derm) Again (hair removal) and Dr. 2021Arnold (magnetotherapy)
Markets and Growth drivers
Laser surgery market trends
Minimally invasive surgeries:
Painless procedures
- Lower risks and side effects
- Shorter hospital stays/Faster recovery
- Savings by Private & National Health Systems
-
Attractive ROI for surgical services providers
-
Rapidly Growing Urology laser market
- Mordor intelligence: 5,51% 2019-2027 CAGR from \$1Bn in 2020
Medical Aesthetics market trend
- Aging demographics and increasing focus on improving appearance and youthfulness;
- Growing interest in non-invasive or minimallyinvasive procedures and awareness of energybased aesthetic treatments
- Growing global obesity rate
- Reductions in procedure costs, attracting a broader patient base
- Normalization and social acceptance of cosmetic procedures
- Rapid growth expected
- Decision Market Reports: CAGR 16,5% to 2027
- Daniel Associates CAGR 10,23 to 2023
- Fortune Business Insights CAGR 13,9 to 2027
- Mordor Intelligence CAGR 11,08% to 2026
Medical Aesthetics: our multi-brand approach
Industrial lasers market trend
Laser cutting applications:
- Laser power increase + Cost reduction: enhanced flexibility, productivity and quality standards in manufacturing processes
- New application verticals
-
Building and construction
-
Products identification and traceability
- Minimal environmental impact
HAIR REMOVAL DEVICES
BODY CONTOURING DEVICES
Skin Devices
Discovery Pico Smart Pico
Unique high end system for laser hair removal
Luxea
The ultimate multi application and multi technology platform
RED Touch
The system for neocollagenesis and tissue regeneration
Urology
FIBER DUST
One of two worldwide players in high power medical fiber lasers
Our novel disruptive technology for the most effective stones micro fragmentation
MonnaLisaGlide- Duoglide
Novel CO2 device for dermatology and gynecology featuring an additional 1540nm laser source
Physiotherapy
MiS (MLS Family) For degenerative neuropathies
Industrial lasers systems
STEEL CUTTING
10 kW Average power in 2020 sales bookings40 kW systemsto come in 2021
Laser cutting systems offer in China
Financial Highlights
Income Statement – FY 2021
| '0 E 0 0 u r o |
/ / 3 1 1 2 1 9 |
% | / / 3 1 1 2 2 0 |
% | / / 3 1 1 2 2 1 |
% | C % a g r |
|---|---|---|---|---|---|---|---|
| d d i t u n a u e |
|||||||
| d l M i e c a |
2 4 2. 1 8 4 |
6 0, 4 % |
2 2 9. 0 6 1 |
5 6, 1 % |
3 1 1. 2 9 0 |
5 4, 5 % |
1 3, 4 % |
| d l I i t n u s r a |
1 5 8. 5 7 7 |
3 9, 6 % |
1 7 9. 0 2 3 |
4 3, 9 % |
2 6 0. 1 1 2 |
4 5, 5 % |
2 8, 1 % |
| R e v e n u e s |
4 0 0. 7 6 1 |
% 1 0 0, 0 |
4 0 8. 0 8 3 |
% 1 0 0, 0 |
5 7 1. 4 0 2 |
% 1 0 0, 0 |
% 1 9, 4 |
| G i r o s s m a r g n |
6. 0 2 1 5 1 |
3 8, 9 % |
6 3 1 4 1. 7 |
3 % 4, 7 |
2 2. 0 3 1 7 |
3 % 7, 1 |
6, 6 % 1 |
| O i E t p e r a n g p e n s e s x |
4 3. 6 2 4 |
1 0, 9 % |
3 4. 1 3 1 |
8, 4 % |
4 7. 8 1 2 |
8, 4 % |
4, 7 % |
| f f S t a e s p e n s e s |
6 6. 0 8 5 |
1 6, 5 % |
6 6. 6 9 2 |
1 6, 3 % |
8 4. 1 7 0 |
1 4, 7 % |
1 2, 9 % |
| E B I T D A |
4 6. 3 1 2 |
1 1, 6 % |
4 0. 8 1 4 |
1 0, 0 % |
8 0. 0 9 1 |
1 4, 0 % |
3 1, 5 % |
| l D t. e p r., a m o r a c c r u a s , |
8. 1 1 4 |
% 2, 0 |
1 0. 7 0 3 |
% 2, 6 |
1 5. 2 3 4 |
% 2, 7 |
% 3 7, 0 |
| I E B T |
3 8. 1 9 8 |
9, % 5 |
3 0. 1 1 1 |
4 % 7, |
6 4. 8 8 5 |
1 1, 4 % |
3 0, 3 % |
| f ( h ) i i N t e n a n c. n c o m e c a r g e s |
4 6 8 |
0, 1 % |
( ) 1. 6 2 7 |
0, 4 % - |
1. 2 7 5 |
0, 3 % |
9 3, 4 % |
| ( ) h O i t t e r n c o m e e p e n s e n e x |
( ) 2 3 |
0, 0 % |
( ) 4 2 5 |
0, 1 % - |
( ) 1 8 5 |
0, 0 % |
1 8 5, 3 % |
| E B T |
3 8. 6 4 4 |
% 9, 6 |
2 7. 9 2 4 |
% 6, 8 |
6 6. 4 2 4 |
% 1 1, 6 |
% 3 1, 1 |
| I t n c o m e a x e s |
9. 8 6 8 |
2, % 5 |
3 8 2 5. |
3 % 1, |
3 0 0 1 7. |
3, 0 % |
3 2, % 4 |
| i i i M t n o r e s |
2. 9 7 5 |
0, % 7 |
2. 2 8 7 |
0, 6 % |
3. 6 8 8 |
0, 6 % |
6 % 1 5, |
| N I N C O E T M E |
2 6. 0 1 7 |
6, % 5 |
2 0. 2 5 5 |
0 % 5, |
4 4 3 6 5. |
8, 0 % |
3 2, 2 % |
Balance sheet – 2021
| '0 E 0 0 u r o |
/ / 3 1 1 2 2 0 |
/ / 3 1 1 2 2 1 |
% V a r. |
|
|---|---|---|---|---|
| d d i t u n a u e |
||||
| l T t t t o a n o n c u r r e n a s s e s |
6 8 3 8 1 1 |
3 6 6 8 1 4 |
0 % 1 7 , |
|
| k l i C i N W t t e o r n g a p a |
0 6 9 1 1 7 |
6 1 4 4 4 1 |
3 0 % 7 , |
|
| / h b l b l O i S T t e r r e c e a e s p a a e s v y |
( ) 3 7 9 4 6 |
( ) 9 1 2 7 8 |
1 4 0 5 % , |
|
| f l N i i i i t t e n a n c a p o s o n |
6 4 1 6 8 |
1 1 5 7 6 6 |
8 0 4 % , |
|
| l b l L i i i i t t o n g e r m a e s |
1 3 0 7 4 |
1 8 0 7 6 |
% 3 8 3 , |
|
| N E i t t e q u y |
2 4 0 6 6 5 |
2 8 7 7 0 1 |
% 1 9 5 , |
|
| l l d i N t t e c a p a e m p o y e |
1 7 6 4 9 7 |
1 7 1 9 3 5 |
% 2, 6 - |
|
| k l l i C i N W t t e o r n g a p a o n s a e s |
2 % 7, 1 |
2 3 % 5 , |
||
| O C R E |
% 1 7, 1 |
3 % 7 7 , |
||
| / ( ) l l d i E B I T N t t e c a p a e m p o y e |
||||
| C a p e x |
1 2 9 4 1 |
2 3 1 5 0 |
Revenue breakdown by area
2022 vs 2021:
Revenue increase > +10%
EBIT 2022 > EBIT 2021
Multiples & ComparablesCurrent Outlook
Multiples
| k h l d 's i h S E t t o c o e r q p e r s a r e u y |
3, 6 |
|
|---|---|---|
| / k l d i j. P B V A r c e o o a u e |
3, 8 |
|
| / ( ) 9 0 % E V E B I T E B I T |
6, 3 1 |
|
| / ( ) l l E V S 9 0 % S a e s a e s |
1, 8 |
|
| l. k E E M C t n a r e a p |
1. 0 8 3, 8 @ |
€ 1 3, 5 8 |
| f l i i i i N t t e n a n c a p o s o n |
@ 1 1 5, 8 |
/ / 3 1 1 2 2 1 |
| / i i l i l F t t t n a n c a n e s m e n s m e r m v |
@ 1 8, 4 |
/ / 3 1 1 2 2 1 |
| l i E V t n e r p r s e a u e |
9 9, 4 7 |
Comparables
| De 3 1st 2 0 2 1 c. , / d l he Me ica Ae ic st t |
Pr ice |
Re ve nu e |
Va % r. Re v. |
EB I T |
EB I T % |
M K. Ca p. |
E V |
/ les E V Sa |
/ E V EB I T |
/ P E |
/ k P Bo o lue Va |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cu te ra |
\$ 4 4, 8 7 |
\$ 2 3 1 |
5 7 % |
\$ 2 |
1 % |
\$ 8 0 8 |
\$ 7 9 3 |
3, 4 |
4 3 3, 4 |
3 8 4, 7 |
1 4, 3 |
| de In Mo |
\$ 3 8, 0 1 |
\$ 3 0 4 |
% 7 3 |
\$ 1 6 7 |
% 5 5 |
\$ 3. 1 1 0 |
\$ 2. 6 9 8 |
8, 9 |
1 6, 1 |
1 6, 3 |
7, 5 |
| ( ) Ve 2 nu s |
\$ 1, 3 9 |
\$ 7 3 |
4 0 % |
\$ ( ) 1 1 |
-15 % |
\$ 7 6 |
\$ 1 3 7 |
1, 4 |
n.a | n.a | 2, 7 |
| d l S isr M ica am e |
\$ 1, 1 3 |
\$ 2 9 4 |
8 2 % |
\$ 4 3 |
1 4 % |
\$ 5 25 |
\$ 4 3 0 |
1, 5 |
1 0, 1 |
1 3, 2 |
1, 5 |
| ic Lu tro n |
€ 1 8, 7 3 |
€ 1 2 8 |
% 5 2 |
€ 2 2 |
% 17 |
€ 4 6 9 |
€ 4 3 4 |
3, 4 |
1 9, 7 |
2 1, 2 |
5, 5 |
| du ia l In str |
|||||||||||
| G ho ics Co I P P to n |
\$ 6, 0 6 1 1 |
\$ 6 1. 4 1 |
2 2 % |
\$ 3 6 8 |
25 % |
\$ 6. 0 1 4 |
\$ 6 6 4. 1 |
3, 2 |
2, 1 7 |
6, 1 7 |
2, 2 |
| im du ie Pr In str a |
€ 15 7 6 , |
€ 4 0 8 |
2 2 % |
€ 1 4 |
3 % |
€ 1 6 5 |
€ 2 3 4 |
0, 6 |
1 6, 6 |
2 9, 1 |
1, 0 |
| 's Ha La n se r |
¥ 4 1, 5 4 |
¥ 1 6. 3 17 |
% 3 6 |
¥ 2. 25 4 |
% 1 4 |
¥ 4 3. 0 5 0 |
¥ 4 5. 0 0 2 |
2, 8 |
2 0, 0 |
2 2, 5 |
3, 7 |
| ic By str on |
C H 9 9 F 7 |
C H 9 3 9 F |
17 % |
C H 0 F 7 |
% 7 |
C H 1. 8 0 F 5 |
C H 1. 3 6 0 F |
1, 4 |
1 9, 4 |
2 3, 9 |
2, 3 |
| l. ( ) E En 1 |
€ 1 3, 5 8 |
€ 5 7 1 |
% 4 0 |
€ 6 5 |
% 1 1 |
€ 1. 0 8 4 |
€ 9 5 0 |
1, 8 |
1 6, 3 |
2 0, 9 |
3, 8 |
Amounts in mln
(1) EV and multiplies as for previous slide
(2) Financials on Sept. 30th, 2021
Contacts
El.En. S.P.A.
Enrico ROMAGNOLI Investor Relations Managertel. +39 055-8826807E-mail: [email protected]
POLYTEMS HIR
Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI - [email protected] Silvia MARONGIU - [email protected] Tel. +39 06-69923324